Discontinuation report VIVAXIM
Report ID | 161652 |
Drug Identification Number | 02248361 |
Brand name | VIVAXIM |
Common or Proper name | Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
Strength(s) | 160UNIT 25MCG |
Dosage form(s) | SUSPENSION SOLUTION SUSPENSION SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1 x 1.0 mL (single dose) dual chamber syringe |
ATC code | J07CA |
ATC description | BACTERIAL AND VIRAL VACCINES, COMBINED |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-05-31 |
Remaining supply date | 2022-05-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | No supply remaining |
Company comments | Discontinuation of the manufacturing of this product. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-06-01 | French | Compare |
v3 | 2022-06-01 | English | Compare |
v2 | 2022-06-01 | English | Compare |
v1 | 2022-06-01 | English | Compare |
Showing 1 to 4 of 4